A Perspective on the Development of c-Jun N-terminal Kinase Inhibitors as Therapeutics for Alzheimer’s Disease: Investigating Structure through Docking Studies
出版年份 2021 全文链接
标题
A Perspective on the Development of c-Jun N-terminal Kinase Inhibitors as Therapeutics for Alzheimer’s Disease: Investigating Structure through Docking Studies
作者
关键词
-
出版物
Biomedicines
Volume 9, Issue 10, Pages 1431
出版商
MDPI AG
发表日期
2021-10-11
DOI
10.3390/biomedicines9101431
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Properties of FDA-approved small molecule protein kinase inhibitors: a 2021 update
- (2021) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Thiophene-Pyrazolourea Derivatives as Potent, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors
- (2020) Yangbo Feng et al. ACS Medicinal Chemistry Letters
- Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases
- (2019) Xiaodong Dou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Emma Nichols et al. LANCET NEUROLOGY
- c-Jun NH 2 -terminal kinase inhibitor bentamapimod reduces induced endometriosis in baboons: an assessor-blind placebo-controlled randomized study
- (2016) Mostafa Hussein et al. FERTILITY AND STERILITY
- Inhibition of c-Jun N-terminal kinase activation reverses Alzheimer disease phenotypes in APPswe/PS1dE9 mice
- (2015) Qiong Zhou et al. ANNALS OF NEUROLOGY
- The ins and outs of selective kinase inhibitor development
- (2015) Susanne Müller et al. Nature Chemical Biology
- Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models
- (2015) Stephen S. Palmer et al. Reproductive Sciences
- Structural Basis and Biological Consequences for JNK2/3 Isoform Selective Aminopyrazoles
- (2015) HaJeung Park et al. Scientific Reports
- Design and Synthesis of Highly Potent and Isoform Selective JNK3 Inhibitors: SAR Studies on Aminopyrazole Derivatives
- (2014) Ke Zheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics
- (2014) Apirat Chaikuad et al. Nature Chemical Biology
- Kinase Drug Discovery – What’s Next in the Field?
- (2013) Philip Cohen et al. ACS Chemical Biology
- Hit-to-lead optimization and kinase selectivity of imidazo[1,2-a]quinoxalin-4-amine derived JNK1 inhibitors
- (2013) Bei Li et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 4-Phenyl-7-azaindoles as potent, selective and bioavailable IKK2 inhibitors demonstrating good in vivo efficacy
- (2012) John Liddle et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of Checkpoint Kinase Inhibitor (S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by Structure-Based Design and Optimization of Thiophenecarboxamide Ureas
- (2012) Vibha Oza et al. JOURNAL OF MEDICINAL CHEMISTRY
- JNK3 Perpetuates Metabolic Stress Induced by Aβ Peptides
- (2012) Sung Ok Yoon et al. NEURON
- Specificity of Linear Motifs That Bind to a Common Mitogen-Activated Protein Kinase Docking Groove
- (2012) A. Garai et al. Science Signaling
- Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor
- (2011) Véronique Plantevin Krenitsky et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- X-ray crystal structure of JNK2 complexed with the p38α inhibitor BIRB796: Insights into the rational design of DFG-out binding MAP kinase inhibitors
- (2010) Andreas Kuglstatter et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration
- (2010) Gary D. Probst et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 1-Aryl-3,4-dihydroisoquinoline inhibitors of JNK3
- (2009) John A. Christopher et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity
- (2008) Stanley D. Chamberlain et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The Crystal Structure of JNK2 Reveals Conformational Flexibility in the MAP Kinase Insert and Indicates Its Involvement in the Regulation of Catalytic Activity
- (2008) David Shaw et al. JOURNAL OF MOLECULAR BIOLOGY
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started